Mustang Share Price

Mustang Share Price

NASDAQ: MBIO | Healthcare
$0.00
-$0.37 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Mustang Stock Performance

Open
N/A
Prev. Close
$0.37
Circuit Range
N/A
Day Range
N/A
Year Range
$0.37 - $1.42
Volume
N/A
Average Traded
N/A

Mustang Share Price Chart

Line chart of the Mustang price trend over the selected period. The price fell overall, ranging from 0.37 to 0.37, ending at 0.37.
$0.00$0.00
L
Show Current Price
H

Mustang Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.47
Revenue (TTM)
$0.00
Return On Equity (TTM)
-53.58%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-77.78%

Mustang Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$0.54-$0.96-$1.07-$0.96
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-77.78%-11.46%10.28%

Mustang Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$77.53-$51.60-$15.75-$1.92
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A33.45%69.48%87.81%

Mustang Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.76.413.57
Current Assets17.598.6111.3578.85
Total Assets17.599.3117.7492.42
Non Current Liabilities0.150.572.2531.04
Current Liabilities7.9112.6115.3715.11
Total Liabilities8.0613.1817.6246.15
Shareholders' Equity9.53-3.870.1246.27

Mustang Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-5.26-11.41-49.48-65.07
Investing1.170.05.89-2.95
Financing14.5311.27-26.0834.06

Corporate Actions

Split
Ex-date: 16 Jan 2025

Split
Ex-date: 04 Apr 2023

About Mustang

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Mustang Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.41
$0.37
-13.15%
Oct 2026
$0.46
$0.43
-18.39%
Sep 2026
$0.55
$0.52
-6.79%
Aug 2026
$0.57
$0.56
-5.08%
Jul 2026
$0.70
$0.59
-15.11%
Jun 2026
$0.73
$0.69
+4.67%
May 2026
$0.75
$0.66
-10.39%
Apr 2026
$0.73
$0.74
+1.09%
Mar 2026
$0.91
$0.73
-28.14%
Feb 2026
$0.98
$1.02
+2.31%
Jan 2026
$1.05
$1.00
+1.22%
Dec 2025
$1.36
$0.98
-30.14%

Mustang Share Price FAQs